Immunai Raises $60M to Reprogram Immunity
The funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform Immunai, a New York and…
The funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform Immunai, a New York and…
ID2020 has launched the Good Health Pass Collaborative along with leading individual companies and organizations in the technology, health, and…
Mobile Healthcare Services Brings Experienced Field Providers to Conquer the Last Mile in Healthcare and Make On-the-Go Patient Care…
The 501(c)(3) Consortium for State and Regional Interoperability aims to help drive individual and population health improvements across the…